Physician profile
Jonathan B Finkel
NPI 1760708358
$13,854.91
in general payments reported to CMS, 2019-2025
31 companies · $3,639 in 2025
The $3,639 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,840 · 2020: $226 · 2021: $503 · 2022: $1,411 · 2023: $2,013 · 2024: $4,223 · 2025: $3,639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,926 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Travel and Lodging: $2,949.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,925.71 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Travel and Lodging | $2,949.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $3,696.03 | 2019-2025 | Lifevest |
| Abbott Laboratories | $3,388.71 | 2023-2025 | Triclip, Mitraclip, Cardiomems |
| Janssen Pharmaceuticals, INC | $1,238.89 | 2019-2023 | Xarelto |
| Pfizer INC. | $1,223.96 | 2019-2025 | |
| Amgen INC. | $795.98 | 2019-2025 | Repatha, Repatha |
| Edwards Lifesciences Corporation | $663.58 | 2025 | Evoque |
| Novartis Pharmaceuticals Corporation | $643.66 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $570.90 | 2019-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $339.28 | 2023-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $196.38 | 2022-2025 | Brilinta, Andexxa, Farxiga |
| Regeneron Healthcare Solutions, INC. | $139.50 | 2019-2024 | Evkeeza |
| Medical Device Business Services, INC. | $137.01 | 2022 | |
| Boston Scientific Corporation | $129.78 | 2019-2024 | Watchman Flx, Latitude Communicator Power Supply |
| Sanofi-Aventis U.S. LLC | $113.89 | 2019 | |
| Kestra Medical Technology Services, INC. | $98.48 | 2025 | Assure Wcd |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $86.84 | 2019 | |
| Genzyme Corporation | $46.79 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $43.66 | 2024 | Arcalyst |
| Amarin Pharma, INC. | $42.33 | 2019-2020 | |
| Heartflow, INC. | $39.75 | 2025 | |
| Alnylam Pharmaceuticals INC. | $29.56 | 2024 | |
| Bracco Diagnostics INC. | $24.68 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.35 | 2025 | |
| Medicomp INC | $23.65 | 2024 | Telepatch Cardiac Monitor |
| Lexicon Pharmaceuticals, INC. | $20.70 | 2024 | |
| Lantheus Medical Imaging, INC. | $19.00 | 2024 | |
| Ionis Pharmaceuticals, INC. | $18.43 | 2025 | Tryngolza |
| Kiniksa Pharmaceuticals, LTD. | $17.60 | 2022 | |
| Bridgebio Pharma, INC. | $15.18 | 2025 | Attruby |
| Biotronik INC. | $13.87 | 2019 | |
| Astellas Pharma US INC | $12.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Finkel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.